|
1.
|
Bevacizumab-Teva
|
Inf Konz 100 mg/4 ml
|
Durchstf 1 Stk
|
257.57
|
296.55
|
01.07.2021
|
|
|
L
|
Nein
|
67886001
|
Teva Pharma AG
|
Bevacizumabum
|
21264
|
01.07.2021
|
- L: 30.06.2026
- L: 30.09.2028
- L: 31.01.2026
- L: 31.08.2028
|
PM
|
21264.01
21264.02
21264.03
21264.04
21264.05
21264.06
21264.07
21264.08
21264.09
21264.10
|
BioS
|
07.16.10.
|
L01FG01
|
|
2.
|
Bevacizumab-Teva
|
Inf Konz 400 mg/16 ml
|
Durchstf 1 Stk
|
962.84
|
1063.55
|
01.07.2021
|
|
|
L
|
Nein
|
67886002
|
Teva Pharma AG
|
Bevacizumabum
|
21264
|
01.07.2021
|
- L: 30.06.2026
- L: 30.09.2028
- L: 31.01.2026
- L: 31.08.2028
|
PM
|
21264.01
21264.02
21264.03
21264.04
21264.05
21264.06
21264.07
21264.08
21264.09
21264.10
|
BioS
|
07.16.10.
|
L01FG01
|